ABSTRACT
Serum specimens collected during the period from September 1970 to April 1971 from hospitalized patients and apparently healthy staff members at risk were tested for the presence of hepatitis-associated antigen (HAA) by the parallel use of three techniques: the complement fixation test, crossover-electrophoresis and immuno-electronmicroscopy.Out of a total of 204 persons investigated 63 (30.9%) were found to harbour the antigen. The HAA-positive sera originated almost exclusively from sporadic cases of acute viral hepatitis (clinically diagnosed as "infectious hepatitis" or "serum hepatitis"). The great majority of the hepatitis cases studied had a history of drug addiction.
Subject(s)
Hepatitis B virus/immunology , Hepatovirus/immunology , Adolescent , Adult , Age Factors , Complement Fixation Tests , Electrophoresis , Female , Hepatitis A/etiology , Hepatitis B/immunology , Hepatitis B Antigens/analysis , Humans , Infusions, Parenteral/adverse effects , Male , Microscopy, Electron , Sex Factors , Substance-Related Disorders/complications , Time FactorsABSTRACT
Live, attenuated mumps virus vaccine (Mumpsvax) was administered to 146 school children 6 to 9 years of age. One child developed clinical mumps nine days after vaccination; epidemiological and serological data strongly suggest that this child had become infected before vaccination. Apart from this single instance there were no apparent clinical reactions that could be ascribed to the administration of the vaccine. Sixty-three of the 146 children with no clinical history of mumps had an initial serum neutralizing antibody titre of less than 1:2. Specific antibodies to mumps virus were detected in 93.5% of the sera of the susceptible children 28 days after vaccination, and the geometric mean antibody titre of these sera was low (1:6). Of the 80 initially seropositive children 21 (26.2%) showed a significant antibody response to the vaccine and this was influenced by the pre-existing antibody level. These data have further demonstrated the safety and efficacy of the live mumps vaccine in children.
Subject(s)
Mumps/prevention & control , Vaccination , Antibody Formation , Child , Humans , Mumps/epidemiology , Mumps/immunology , Mumps Vaccine , Mumps virus/immunology , Neutralization TestsABSTRACT
Under the auspices of WHO an investigation was made by 9 laboratories in different parts of the world on the distribution of rubella antibodies in girls and women of child-bearing age. In the first part of the study the objective was to determine the reliability and reproducibility of the tests employed. It was found that there were no significant differences in the variability of the titres obtained in different laboratories when the results were compared with those obtained by repeatedly testing the same sera in one laboratory.In the second part of the study sera were obtained from girls in schools and women attending clinics and health centres. They were not taken from random samples of the populations. In most of the studies the pattern of development of antibody was similar. About half the persons had antibody at 6-8 years of age and 80%-87% at 17-22 years of age, the percentage remaining relatively constant thereafter. The island populations of Trinidad and Jamaica and a rural area of Japan were, however, found to have significantly fewer women with antibodies than urban areas in Europe or the Americas.
Subject(s)
Antibodies/analysis , Rubella/immunology , Adolescent , Adult , Australia , Child , Epidemiologic Methods , Europe , Asia, Eastern , Humans , Jamaica , Japan , North America , Serologic Tests , South America , Trinidad and TobagoSubject(s)
Antibodies/analysis , Measles/immunology , Australia , Jupiter , Jamaica , Japan , North America , South America , Trinidad and TobagoABSTRACT
Under the auspices of WHO an investigation was made by 9 laboratories in different parts of the world on the distribution of rubella antibodies in girls and women of child-bearing age. In the first part of the study the objective was to determine the reliability and reproducibility of the tests employed. It was found that there was no significant differences in the variability of the titres obtained by repeatedly testing the same sera in one laboratory. In the second part of the study sera were obtained from girls in schools and women attending clinics and health centres. They were not taken from random samples of the populations. In most of the studies the pattern of development of antibody was similar. About half the persons had antibody at 6-8 years of age and 80 percent-87 percent at 17-22 years of age, the percentage remaining relatively constant thereafter. The island populations of Trinidad and Jamaica and a rural area of Japan were, however, found to have significantly fewer women with antibodies than urban areas in Europe or the Americas.(AU)